- Corporate Officers - D
- Divis Gregory J
Insider Trading History of Divis Gregory J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Divis Gregory J since 2008.
This trader's CIK number is 1410677.
At the time of last reporting, Divis Gregory J was the Chief Executive Officer of Avadel Pharmaceuticals Plc. (stock ticker symbol AVDL).
Also see all insider trading activities at Avadel Pharmaceuticals Plc.
Note that in the past
Divis Gregory J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avadel Pharmaceuticals Plc (AVDL) by Divis Gregory J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | AVDL | 10,000 | $99,706 | 0 | $0 | 0 | $0 |
| 2023 | AVDL | 10,000 | $132,000 | 0 | $0 | 0 | $0 |
| 2022 | AVDL | 50,000 | $102,499 | 0 | $0 | 0 | $0 |
| 2020 | AVDL | 13,000 | $101,153 | 0 | $0 | 0 | $0 |
| 2019 | AVDL | 19,000 | $97,470 | 0 | $0 | 0 | $0 |
| 2018 | AVDL | 16,000 | $96,000 | 0 | $0 | 0 | $0 |
| 2017 | AVDL | 10,600 | $98,760 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kv Pharmaceutical Co /de/ (KVA / KVB) by Divis Gregory J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | KVA / KVB | 0 | $0 | 0 | $0 | 1,225 | $35,035 |
Yearly summary of insider trading at Jaguar Health, Inc. (JAGX) by Divis Gregory J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | JAGX | 0 | $0 | 0 | $0 | 12,133 | $0 |
Insider trading activities at 3 companies by Divis Gregory J:
1. Avadel Pharmaceuticals Plc (AVDL)
2. Kv Pharmaceutical Co /de/ (KVA / KVB)
3. Jaguar Health, Inc. (JAGX)
Table 1. Insider trading of Avadel Pharmaceuticals Plc (AVDL) by Divis Gregory J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-06 | AVDL | Buy | 9,598 | 9.98 | 95,759 |
| 2024-12-09 | AVDL | Buy | 402 | 9.82 | 3,947 |
| 2023-08-10 | AVDL | Buy | 10,000 | 13.20 | 132,000 |
| 2022-05-27 | AVDL | Buy | 50,000 | 2.05 | 102,499 |
| 2020-08-12 | AVDL | Buy | 13,000 | 7.78 | 101,153 |
| 2019-11-15 | AVDL | Buy | 19,000 | 5.13 | 97,470 |
| 2018-06-26 | AVDL | Buy | 16,000 | 6.00 | 96,000 |
| 2017-09-12 | AVDL | Buy | 10,600 | 9.32 | 98,760 |
Table 2. Insider trading of Kv Pharmaceutical Co /de/ (KVA / KVB) by Divis Gregory J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-07-18 | KVA / KVB | Option Ex | 1,225 | 28.60 | 35,035 |
Table 3. Insider trading of Jaguar Health, Inc. (JAGX) by Divis Gregory J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-18 | JAGX | Option Ex | 12,133 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Divis Gregory J
(Chief Executive Officer of Avadel Pharmaceuticals Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.